About 28,905 results

ALLMedicine™ Migraine Center

Research & Reviews  8,549 results

Risk factors in central retinal vein occlusion: A multi-center case-control study condu...
European Journal of Ophthalmology; Edoardo TB, Fernanda P et. al.

Dec 3rd, 2021 - To explore the risk factors for central retinal vein occlusion (CRVO) by comparing a large sample of patients with healthy controls. Multi-center case-control study. The study group includes patients affected by central retinal vein occlusion, con...

Ginger for Migraine.
The Journal of Clinical Psychiatry; Andrade C

Dec 2nd, 2021 - Many preclinical and clinical studies have examined the potential benefits of ginger extracts for a range of medical disorders. Ginger has been found to reduce both pain and nausea and has therefore also been studied in the context of migraine hea...

Core outcome set for preventive intervention trials in chronic and episodic migraine (C...
BMJ Open; Haywood K, Potter R et. al.

Dec 2nd, 2021 - Typically, migraine prevention trials focus on reducing migraine days. This narrow focus may not capture all that is important to people with migraine. Inconsistency in outcome selection across trials limits the potential for data pooling and evid...

Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4...
Journal of Neurology, Neurosurgery, and Psychiatry; Ferrari MD, Reuter U et. al.

Dec 1st, 2021 - To evaluate individual and group long-term efficacy and safety of erenumab in individuals with episodic migraine (EM) for whom 2-4 prior preventatives had failed. Participants completing the 12-week double-blind treatment phase (DBTP) of the LIBER...

see more →

Guidelines  15 results

Guidelines of the International Headache Society for controlled trials of preventive tr...
Cephalalgia : an International Journal of Headache; Diener HC, Tassorelli C et. al.

Jul 30th, 2020 - Clinical trials are a key component of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Contro...

ACR Appropriateness Criteria® Cerebrovascular Disease-Child.
Journal of the American College of Radiology : JACR; , Robertson RL et. al.

May 7th, 2020 - Stroke is an uncommon but an important and under-recognized cause of morbidity and mortality in children. Strokes may be due to either brain ischemia or intracranial hemorrhage. Common symptoms of pediatric acute stroke include headache, vomiting,...

Pharmacologic Acute and Preventive Treatment for Migraine in Children and Adolescents.
JAMA Neurology; Szperka CL, VanderPluym JH et. al.

Dec 10th, 2019 - Pharmacologic Acute and Preventive Treatment for Migraine in Children and Adolescents.|2019|Szperka CL,VanderPluym JH,Oakley CB,|prevention & control,

Aids to management of headache disorders in primary care (2nd edition) : on behalf of t...
The Journal of Headache and Pain; Steiner TJ, Jensen R et. al.

May 23rd, 2019 - The Aids to Management are a product of the Global Campaign against Headache, a worldwide programme of action conducted in official relations with the World Health Organization. Developed in partnership with the European Headache Federation, they ...

Guidelines of the International Headache Society for controlled trials of preventive tr...
Cephalalgia : an International Journal of Headache; Abu-Arafeh I, Hershey AD et. al.

Apr 6th, 2019 - Because the results of clinical trials of investigational treatments influence regulatory policy, prescribing patterns, and use in clinical practice, high quality trials are an essential component of the evidence base for migraine. The Internation...

see more →

Drugs  721 results see all →

Clinicaltrials.gov  422 results

Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

Dec 1st, 2021 - This study will assess the safety, tolerability, and efficacy of Atogepant 60 mg compared with placebo in episodic migraines in participants who previously failed 2 to 4 classes of oral prophylactic treatments.

A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Patients 6 to 17 Years of Age

Nov 26th, 2021 - The primary objective of the study is to evaluate the effectiveness of fremanezumab as compared to placebo for the preventive treatment of chronic migraine (CM). Secondary objectives are to further demonstrate the efficacy of Fremanezumab as compa...

Natural History Study of CADASIL

Nov 25th, 2021 - Small vessel diseases are conditions characterized by the narrowing of small arteries leading to an imbalance of blood supply upon demand. This results in a progressive chronic hypoperfusion with detrimental outcomes for the affected organ system ...

Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine

Nov 24th, 2021 - This is a clinical trial to assess the efficacy of botox treatment of the sphenopalatine ganglion as an add-on treatment in drug resistant migraine. An injection targeting the ganglion is made possible by an image-guided device developed specifica...

Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Nov 19th, 2021 - Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in chil...

see more →

News  1,830 results

Opioids for headache?
Jim Kling

Nov 29th, 2021 - The use of opiates in the treatment of headache has a controversial history, and it remains a matter of debate today. Some believe that the medications, though risky, can be a useful tool in the neurologist’s treatment arsenal, while others argue.

Headache is a common post–COVID-19 complaint
Jim Kling

Nov 24th, 2021 - Post–COVID-19 headache is a common and sometimes persistent problem. It may take the form of new-onset headache, or exacerbations of preexisting headache conditions such as migraine.

Botulinum toxin for chronic pain: What's on the horizon?
MDedge Family Medicine; Caleb Dickison, DO, CAQSM, Jeffrey C. Leggit, MD, CAQSM

Nov 12th, 2021 - Botulinum toxin (BoNT) was first approved by the US Food and Drug Administration (FDA) for the treatment of strabismus and blepharospasm in 1989. Since then, approved indications have expanded to include spasticity, cervical dystonia, severe axill.

Aaron Beck, Father of Cognitive Behavioral Therapy, Dies at 100

Nov 1st, 2021 - Dr Aaron Beck Aaron "Tim" Beck, MD, known as the father of cognitive behavioral therapy (CBT), died on Monday in Philadelphia. He was 100. Beck's pioneering career in psychoanalysis spanned more than seven decades, yielding more than 600 published...

Trending Clinical Topic: Hot Flashes

Oct 22nd, 2021 - Each week, we identify one top search term, speculate about what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, share them with us on Twitter or Facebook. Key findings ...

see more →

Patient Education  25 results see all →